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Background: Patient preferences are important to consider in the decision-making process for 
colorectal cancer (CRC) screening. Vulnerable populations, especially, exhibit lower screening 
uptake. This systematic review describes studies on vulnerable populations’ preferences 
regarding CRC screening. 
Methods: We searched the PubMed, CINAHL, PsychInfo, Scopus, and Web of Science 
databases for articles published between January 1, 1996 to December 31, 2017. We screened 
studies for eligibility and using a standardized spreadsheet, abstracted and compared study 
designs and outcomes. 
Results: A total of 44 articles were selected and are organized by the types of vulnerable 
population(s) whose preferences are reported. Of these studies, 17 report on preferences among 
racial/ethnic minorities, 11 among multiracial/multiethnic minorities, 7 among low-income 
groups, 6 among veterans, 2 among rural residents, and 1 among immigrants. 
Conclusion: The heterogeneity in outcomes, study design, and populations of the selected 
studies demonstrate the wide spectrum of preferences of vulnerable populations. No specific 
modality was overwhelmingly supported by vulnerable populations, but attributes such as 
accuracy and sensitivity proved to be important features. An increase in the CRC screening rate 
may be achieved through the alignment of vulnerable populations’ preferences with provider 








 Colorectal cancer (CRC) is the third most common type of cancer in the United States 
and the second leading cause of cancer deaths. In 2017, there were an estimated 135,430 new 
cases diagnosed (95,520 cases of colon cancer and 39,910 cases of rectal cancer) and an 
estimated 50,260 CRC-specific deaths.1 CRC is expected to cost the U.S. healthcare system $14 
billion per year.2 Screening has been shown to reduce the incidence and mortality of CRC by 30-
60% and has the potential to save an estimated 18,800 lives per year.3,4 CRC screening is 
imperative for early detection and appropriate treatment, especially since early stage CRC is 
asymptomatic.5 The US Preventive Services Task Force (USPSTF) has recommended CRC 
screening using colonoscopy, fecal occult blood testing (FOBT), or sigmoidoscopy for adults age 
50 to 75 years.6 The recommended time interval between screenings depends on the modality 
used (e.g. colonoscopy every ten years, sigmoidoscopy every five years, FOBT annually). Of 
these, colonoscopy and FOBT are the most common.7 
 The U.S. has recently seen an increase in CRC screening, yet the 2015 national rate of 
62.6% is well below the Healthy People 2020 target of 70.5% set by the U.S. Department of 
Health and Human Services.8,9 The national rate is also lower than breast and cervical cancer 
screening rates (72% and 81% respectively).8 CRC screening is even lower in many vulnerable 
sub-populations. Patients who are racial and ethnic minorities, foreign born, low-income, are 
publicly insured or uninsured, and live in rural areas are at greater risk of not being screened.10-15  
 One of several factors contributing to lower screening rates is suboptimal decision 
making, including poor incorporation of patient preferences.16 Communication between 
providers and patients is important for improving CRC screening uptake.17 Shared decision 
making, the process of the physician and patient working together to mutually agree on an 
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optimal option, has been increasingly advocated for screening and other types of preventive 
care.18 There are multiple options for CRC screening modality that present unique combinations 
of test characteristics, such as accuracy, invasiveness, and comfort.19 Individuals weigh these 
characteristics in deciding their preference for CRC screening. For example, some patients may 
prefer FOBT, due to its non-invasive nature, and are more likely to engage in screening when 
presented with the choice of this option. Presenting choices of screenings that match with 
individuals’ preferences may increase CRC screening uptake.  
 Systematic reviews have assessed preferences of CRC screening within the general 
population.20-22 These reviews reported that the general population values accuracy and clinical 
effectiveness but did not exhibit an overwhelming preference for a modality. However, screening 
rates are lower among vulnerable patients and there is significant evidence that vulnerable 
patient populations face increased barriers to preventive care.23-27 Given these unique barriers, 
preferences may differ between the general population and underserved patients. Thus, an 
understanding of preferences, specifically among underserved patient populations is critical to 
increasing their screening rates.  To our knowledge, this is the first systematic review to address 
CRC screening preferences among vulnerable populations. 
Problem Statement 
 CRC mortality rates have started to decline, largely due to improved screening rates, but 
many people have yet to be screened. Vulnerable populations’ preferences concerning CRC 
screening practices, including screening modality, test features, decision making, and methods of 
communication about screening options, and provides insight into how to best target 





 We conducted a systematic review according to the Preferred Reporting Items for 
Systematic Reviews and Meta-analyses (PRISMA) guidelines.28 Studies eligible for review met 
specific criteria outlined below in Table 1. 
Table 1: Inclusion/Exclusion criteria 
Criterion Inclusion Exclusion 
Population Vulnerable populations:  
• Rural residents 
• Racial/ethnic minorities 
• Low-income 




• Lesbian, Gay, Bisexual, Transgender, 
Queer (LGBTQ) populations 
• Medicaid enrollees 
• Dually-insured (Medicare/Medicaid) 
• Uninsured 
• Veterans 
All other populations 
Comparison Modalities of CRC screening as well as 
screening features 
All other 
Outcome Preferences for incentives, modality, 
program design, service delivery, 
communication method 
All other 
Time January 1, 1996 to December 31, 2017 Any article outside of 
this range 
Setting All settings (including international studies) None 
Study Design Quantitative, qualitative, and mixed-methods 







 We searched in the PubMed, CINAHL, PsycInfo, Scopus, and Web of Science databases 
for articles published from January 1, 1996 to December 31, 2017 (Figure 1). We chose this 
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timeframe because the USPSTF released its first guidelines on CRC screening in December 
1995.29 The following search string was used to search for relevant articles:  
((“colorectal” AND “cancer” OR “colon” AND “cancer”) AND (“screening” OR “detection” OR
 “testing” OR “test”) AND ((“preference” OR “preferences” OR “perception” OR “perceptions”)
 OR (“discrete” AND “choice”) OR (discrete AND choices))) AND PUBYEAR > 1995  
The specific vulnerable populations identified in the inclusion criteria were not included in this 
search string. While our focus was on underserved populations, we did not exclude studies 
outright if they were not specifically about vulnerable populations. Instead, we included the 
studies that contained subgroup analyses regarding screening preferences for one or more 
vulnerable populations and excluded those without a subgroup analysis.   
 In total, 4,269 articles were found and imported into F1000, a reference manager, where 
articles were de-duplicated. The remaining 2,153 articles were then transferred to Covidence and 
then further deduplicated, leaving 2,106 articles to be screened.  
 Using Covidence, two reviewers independently screened the study titles and abstracts 
according to the predetermined inclusion/exclusion criteria. The two reviewers started with a 
small pool of 20 articles to ensure consistency and to further refine the inclusion/exclusion 
criteria. Following the title and abstract screening process, the two reviewers resolved 
discrepancies in their ratings. If a consensus could not be reached, a third reader made the final 
decision. The two reviewers then engaged in a full-text review of the remaining 154 articles to 
assess whether each article should be included or excluded and to categorize the excluded 
articles by reason of exclusion. Discrepancies regarding whether the article should be included or 
excluded, as well as the reason for exclusion, were resolved by the two reviewers with the third 
reader making the final decision about any remaining discrepancies.  




The two reviewers abstracted the data from the remaining articles into a literature matrix using 
Microsoft Excel 2010. The literature matrix included fields such as title, sample size, study 
design, vulnerable population studied, baseline population characteristics, outcome measure, and 
risk of bias. 
Results 
 A total of 44 articles that address patient preferences regarding CRC screening among 
underserved groups are included in this systematic review. The selected articles are organized by 
the types of vulnerable population(s) whose preferences are reported. Of these studies, 17 report 
on preferences among racial/ethnic minorities, 11 among multiracial/multiethnic minorities, 7 
among low-income groups, 6 among veterans, 2 among rural residents, and 1 among immigrants. 
Notably, many studies elicited preferences from more than one underserved population, since 
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these categories are not necessarily mutually exclusive. For example, studies often included 
racial or ethnic minorities as well as low-income individuals. For this analysis, studies were 
categorized based on the vulnerable population prioritized during sampling and in the analysis. 
 The multiracial/multiethnic minorities category was created because some studies did not 
focus on or have an overwhelming majority of participants from a single racial group. Other 
studies focused on assessing the preferences of a specific racial group or had a large portion of a 
racial group in their study population due to their sampling.  
 Grouping by outcomes and study design were considered but categorizing by vulnerable 
population will best assist public health officials designing interventions for these underserved 




Racial/Ethnic Minorities (n=17) 


















Survey 423 Preference of 
sDNA vs 
colonoscopy 
Both whites and African 
Americans preferred the sDNA 
test. More African Americans 
than whites preferred a 
colonoscopy. African Americans 
perceived the sDNA test to be 
more accurate but were more 







262 Preference for 
FOBT and 
colonoscopy 
Control*: 45.8% preferred FOBT 









Race was not associated with test 
preference. 59% colonoscopy, 
17% FOBT, 14% sDNA, and 








Survey 395 Preference for 
source of 
information 
Top four preferred sources of 
information: doctor/provider, 
health brochures, television, and 












Following the educational lecture 
session, 33% of the participants 
preferred colonoscopy and 26% 
preferred for FOBT. The rest 








28 Preferences for 
FOBT and FIT 
FIT was preferred because it 





151 Preference for 
source of 
information 
Educational seminar (42%) was 
most preferred, followed by 









38 Testing options, 
travel time, 
money paid for 
screening, and the 
portion of the cost 
of follow- up care 
paid out of pocket 
Option of 2 or 3 tests was 
preferred over either colonoscopy 
or the stool test alone. Cost 
variables were more important 











Black versus white ethnicity was 
associated with greater odds of 
preferring to share decision 





Survey 780 Decision 
preferences 
(collaborative vs. 
active vs. passive) 
The majority preferred a 
collaborative role (53.3%) 
compared to a passive (26.4%) or 
active role (20.3%). 
Myers, 
200840 




122 exhibited preference for 
colonoscopy and 32 exhibited 













Preferred colonoscopy and FOBT 















More whites than African 
Americans preferred FOBT, 
while more African Americans 
than whites preferred 
colonoscopy. African Americans 
overall preferred colonoscopy, 











Colonoscopy was preferred 
(59%) followed by FOBT (26%), 
flexible sigmoidoscopy (5%), 
DCBE (4%) and FOBT plus 
flexible sigmoidoscopy (3%); 
only 3% did not identify a 
preferred option. Majority 
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preferred shared decision-making 
approach (53%) and 28% 








Non-white: 42.5% prefer SB-
DNA, 30.5% prefer FOBT, 













African Americans were more 
likely to prefer colonoscopy and 





Survey 438 Sex and ethnicity 
preference for 
endoscopists 
Hispanic women more likely to 
have preference for sex of 
endoscopist. Hispanics were more 
likely to prefer ethnicity of 
endoscopist 
 
 Ten of the seventeen studies focused on preferences among African Americans, four 
among Hispanics/Latinos, two among non-whites, and one among Korean-Americans. Most 
observed preferences in terms of modality and testing features and used a variety of outcome 
measures and study designs. Three articles looked at preference of decision making, two 
investigated preferred sources of information, and one considered preference for the sex and 
ethnicity of endoscopists.  
 Six articles reported colonoscopy as the most preferred modality, two of the articles 
reported sDNA as the most preferred modality, and two of the articles indicated that FOBT or 
FIT were the most preferred modality. All six of the articles reporting colonoscopy as the 
preferred modality focused on African-Americans. One of the articles on sDNA testing, Abola et 
al, focused on African-Americans, while the other article on sDNA testing did not specify a 
racial group in its study population.  
 Three articles investigated screening features. Two of these articles focused on African-
Americans. These two studies reported that African-Americans preferred colonoscopy and 
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valued its accuracy. Martens et al. employed a discrete choice experiment for a Hispanic/Latino 
population and noted that cost attributes were more important than the testing attributes tested.  
 Zapatier et al. found that Hispanics overall exhibited a preference for the sex and 
ethnicity of endoscopist. The two articles that discussed preference for source of information 
focused on two different racial groups, but both indicated sources in their respective languages. 
Jo et al found that Korean media was one of the preferred sources of information and Ellison et 
al reported that someone who spoke the language was a preferred source as well. The three 
articles that studied preference of decision making indicated a preference for shared decision 
making and collaborative decision making compared to a passive and patient-dominant approach 
to decision making. 
Multiracial/Multiethnic Minorities (n=11) 





















64.4 % colonoscopy, 
31.1 % preferred 
Cologuard, 2.2 % 
preferred computed 
tomographic 
colonography, and 2.2 






Survey 323 Preference for 
colonoscopy vs. 
FOBT 
Preference for FOBT 
remained greater 













No racial difference 
found 34.7% FOBT, 
41.1% colonoscopy, 
12.7% sigmoidoscopy, 
5.7% barium enema, 
and 5.8% did not 








212 1) Preference for 
colonoscopy, FOBT, 
sigmoidoscopy, 
barium enema  
2) Test attributes 
1) Hispanics more 
likely to prefer FOBT, 
African Americans 




2) African Americans 
rated accuracy as most 
important. More 
African Americans 
rated the frequency of 
test as important 
compared to other 
groups 
Quick, 201351 Hispanic/Latinos 
& African 
Americans 
Survey 418 Preference for 
colonoscopy vs. FIT 
Colonoscopy was the 
most preferred test at 
baseline when 
compared to FIT 
Sheikh, 200452 Hispanic/Latinos 
& African 
Americans 
Survey 193 Preference for FOBT, 
sigmoidoscopy, 
colonoscopy 
Hispanics were more 











168 Preferences of 13 






amount of colon 
examined, discomfort, 
and complications as 
most important. 





30 Preference for 
colonoscopy, FOBT, 
barium enema, any 
test, flexible 
sigmoidoscopy, none, 
up to doctor 
African Americans 
(n=10): preference for 
FOBT (4), barium 
enema (2), 
colonoscopy (1), any 
test (1), flexible 
sigmoidoscopy (1), up 




FOBT (2), any test (2), 
barium enema (1), 
flexible sigmoidoscopy 
(1), none (1), up to 
doctor (0). 
Taber, 201455 Hispanic/Latinos 
& African 
Americans 
Survey 100 Preference for 
colonoscopy, 
sigmoidoscopy, 
FOBT, and SEPT9 
(blood test) 
Blacks remained less 
likely to prefer SEPT9 
testing. Unscreened 
blacks were more 
likely to prefer 
colonoscopy 
Wolf, 200656 Hispanic/Latinos 
& African 
Americans 
Survey 216 Preference for FOBT, 
colonoscopy, or no 
preference; preference 
for test features 
The majority preferred 
FOBT over 
colonoscopy. Among 
those who preferred 





Wolf, 201657 Hispanic/Latinos 
& African 
Americans 
Survey 453 Preference for 
colonoscopy vs. home 
stool test; 
Whites were more 
likely to express a 
preference for home 
stool test (HST) than 
non-whites  
 
 Seven of the selected studies were executed using surveys and every study measured 
preference in terms of modality and test features and included African Americans and 
Hispanic/Latinos in their study populations. Eight of these studies looked at only preference of 
modality, two of these examined test attributes as well, and one study focused on just test 
attributes. Five of the eleven studies indicate a preference for colonoscopy, while four of the 
studies suggested that a certain racial group preferred FOBT. Shokar et al, one of the four 
studies, exhibited very low sample sizes of African Americans and Hispanic/Latinos. Wolf et al 
also noted that whites were more likely to prefer home stool tests than non-whites, while Sheikh 
reported that Hispanics were more likely to prefer sigmoidoscopy. A range of preferences for 
modality have been uncovered in our findings. 
 It is difficult to compare studies that investigated test attributes, since each study used 
different test attributes and different study designs. However, the studies suggest that accuracy, 
frequency of test, discomfort, and convenience are all important attributes for African Americans 
and Hispanic/Latinos. 
Low-income (n=7) 







Outcome Measure Outcome 
Cho, 201758 Questionnaires 396 Preference for FIT 
vs. colonoscopy 




Questionnaires 2767 Willingness to pay Low-income people more likely to be willing 







437 Preferences and 
acceptance of FIT 
vs. colonoscopy 
Low-income was not associated with 
preference for screening 
Waller, 
201561 
Survey 1964 Preference for 
expert 
recommendation 




Survey 3430 Preference for FIT 
vs. colonoscopy 




Survey 7845 Preference for FIT 
vs. colonoscopy 
Low-income associated with higher odds of 
changing preference from colonoscopy to FIT 
after educational session 
Xu, 201564 Survey 667 Preference for FIT 
vs. colonoscopy 
As household incomes increased, patients 
tended to prefer colonoscopy. 
 
 Among the seven studies on low-income patient preferences, six were conducted in an 
international setting. Xu et al. is the only domestic study in this group. Five out of the seven 
studies focused on preference of FIT vs. colonoscopy, while the other two studies focused on 
willingness to pay and preference for an expert recommendation. In a willingness to pay study, 
Frew et al found that low-income patients were less willing to pay for CRC screening as 
expected. Waller et al did not find any association between being low-income and preference for 
expert recommendation. Xu et al, Cho et al, and Wong et al point to a possible relationship 
between low-income and FIT preference. Wong et al showed that low-income participants were 
more likely to shift preferences from colonoscopy to FIT after an educational session, while the 
other two studies found low-income to be associated with FIT preference. However, Saengow et 
al and Wong et al did not find any association with income and preference. Given that a large 
proportion of these studies were international, cultural and social contexts may have influenced 
the results of these studies making it difficult to generalize to underserved populations in the 
U.S. 
Veterans (n=6) 






Study Design Sample Size Outcome Measure Outcome 












70 Preference among 




Colonoscopy was preferred over 
all other screening modalities 
Imaeda, 201067 Maximum 
Differences 
Scaling tool 
92 Preference for test 
attributes and 
modalities 
Colonoscopy was preferred, and 
subjects viewed sensitivity of the 
test, the risk of a perforation and 
the potential need for a second 
test as most important. 





95% of the study population 
preferred CTC 





(DCBE) or no 
screening 
Preference: colonoscopy (37%), 
FOBT (29%), no preference 
(22%), sigmoidoscopy (5%), do 










Proportion of subjects who 
preferred computed tomographic 
colonography over optical 
colonoscopy was not 
significantly different 
 
 Six studies sampled patients exclusively from the Veterans Health Administration 
(VHA). These studies primarily focused on preferences of modality. Four out of six studies 
indicated that colonoscopy was the preferred modality for CRC screening among veterans. 
Rajapaksa et al found that the preference of computed tomographic colonography over 
colonoscopy was not significantly different. This study also found that racial/ethnic minorities 
were less likely to prefer computed tomographic colonography over colonoscopy. Moawad et al 








Study Design Sample Size Outcome Measure Outcome 
Pham, 201771 Questionnaire + 
Focus Group 
Interviews 
18 Understand patient 
preferences for FIT 
characteristics 
Patients preferred FITs 
that required 1 sample, 
used a probe and vial, 
and had 
descriptive instructions  
 
Pignone, 201472 Discrete Choice 
Experiment 
150 mean utility levels for 
testing options, travel 
time, money paid for 
screening, and out of 
pocket cost of follow up 
care 
Costs were more 
important than testing 
options and travel time 
 
 Two studies focused primarily on rural populations’ preferences for CRC screening. 
Pham et al studied a rural population that consisted of predominantly Hispanics, but a subgroup 
analysis to see whether preference varied by race was not conducted. Pham et al suffered from a 
relatively low sample size (n=18), which would have made it difficult to draw significant 
statistical inferences on differences in race. Pignone et al sampled from a rural setting as well 
and included a large percentage of uninsured and low-income individuals.  
 While focused on rural populations, these two articles varied in methodology and design. 
Pham et al studied patient preferences for characteristics of fecal immunochemical test (FIT), a 
specific screening modality using stool samples, while Pignone et al studied preferences for 4 
test attributes. Pham et al. showed that the study population enjoyed the convenience of the FIT 
compared to a colonoscopy, while Pignone et al. showed that the study population favors having 
the option of stool testing, rather than only colonoscopy. 
Immigrants (n=1) 















815 1) Preference among stool, 
blood, and combi tests 
2) How do preferences 
differ according to 
sociodemographic 
characteristics 
3) Preference in terms of 
test attributes  





3) Sensitivity, risk 
reduction, scientific 
evidence are favorable 
attributes 
 
 Only one article was found with information on immigrants’ preferences of CRC 
screening. The article was conducted in the Netherlands and collected sociodemographic 
variables as well as preferences regarding stool, blood, and combination tests (combination of 
the stool and blood tests). The study found that individuals who are higher educated, born in the 
Netherlands, younger, and have experienced a colonoscopy are more likely to prefer either 
screening test than people who are less educated, immigrants, older, and have not experienced a 
colonoscopy. In general, the study also found that sensitivity, risk reduction of CRC death, and 
scientific level of evidence were favorable attributes. However, no subgroup analysis was done 
to elicit whether immigrants had the same preferences in terms of testing attributes. 
Discussion 
 A relatively large number of studies addressed preferences among vulnerable populations 
(n=44). Out of these selected articles, seven were done in an international setting. Six of the 
seven international studies analyzed low-income populations’ preferences. Most of these studies 
investigated the preferences of racial/ethnic/multiracial minority groups with few studies that 
focused on the rural population and immigrants. The one study on immigrants was conducted 
internationally as well. The U.S. contains large swaths of rural areas and a growing immigrant 
population, making rural and immigrant people important populations to consider for CRC 
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screening.74,75 Many studies, especially those that focused on Hispanic/Latinos, may have 
captured immigrant populations, but did not record immigrant status. There also have yet to be 
studies assessing preferences in some of the vulnerable populations that were incorporated in the 
inclusion criteria. 
 In terms of outcomes, many studies across vulnerable groups focused on preference for 
modality, especially contrasting colonoscopy vs. stool tests. Many studies pointed to 
colonoscopy as the preferred modality among racial/ethnic minorities and veterans, while low-
income populations seemed to prefer stool tests. There was no overwhelming and conclusive 
evidence on this issue and may require additional focus on information on test attributes to 
further our understanding on what modality would be the ideal screening option. A handful of 
studies argued that vulnerable groups in their study populations preferred stool tests. Studies that 
investigated test attributes tended to find that accuracy, sensitivity, costs, frequency of test, and 
discomfort were all important attributes to consider. Accuracy and sensitivity were often 
associated with colonoscopy, while convenience and comfort were often associated with stool 
tests. 
 An interesting preference that few studies have focused on is preference for decision 
making. All the studies that measured preference for decision making pointed to preference for 
shared decision making. This displays the importance of patient-provider communication for the 
CRC screening process and points to a willingness to engage in productive and collaborative 
efforts to receive screening by vulnerable populations. This is paramount, since consideration of 
patient preferences in terms of testing attributes can be combined with the expertise of a provider 
to reach an optimal screening strategy. This review targeted patient preferences, but physician 




 The studies selected displayed a wide range of heterogeneity in study design and 
outcomes across all studies, making them difficult to compare. In addition, the intersectionality 
of identities among the vulnerable populations made it difficult to elicit a specific preference for 
a singular categorization. As a result, generalizations and overarching conclusions on specific 
vulnerable groups could not be made, due to the variety of factors that are involved in 






 There were many strengths of this study, including the large number of databases 
searched over a long study period and this being the first systematic review that addresses the 
preferences among underserved populations.  
Implications and Future Directions 
 As noted before, the preferences for many traditionally vulnerable groups have yet to be 
assessed and may be of interest for the future. There may need to be more standardized methods 
to capture preferences for vulnerable group specifically, such as discrete choice experiments. 
There have been many discrete choice experiments done for the general population, but few have 
focused on vulnerable groups. To increase CRC screening overall, special attention must be paid 




 The plurality in outcomes, study design, and populations of the selected studies 
demonstrate the wide spectrum of preferences of vulnerable populations. This review echoes the 
results of previous systematic reviews done on preferences for CRC screening of the general 
population in that there is no specific modality that is overwhelmingly supported by vulnerable 
populations and that attributes such as accuracy and sensitivity are important features to 
consider. Further improvements in the CRC screening rate may be achieved through the 
alignment of vulnerable populations’ preferences with provider preferences through shared 
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